6 NDA's. Impressive. You'd think they'd be able to pull a decent partnership out of the out with competing suitors. CYP is (for longer holders a deaying one) a call option for me. Risky in the present cost of capital climate as to where you buy in, but the reward potential there. Six NDA's gives that view some credence.
Thanks for the information Rossi.
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Webinar Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.0¢

Ann: Investor Webinar Presentation, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $14.06K | 87.07K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 46112 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 55253 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 46112 | 0.160 |
5 | 58902 | 0.155 |
6 | 106866 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 55253 | 4 |
0.170 | 70193 | 3 |
0.175 | 87450 | 3 |
0.180 | 108494 | 4 |
0.185 | 35990 | 1 |
Last trade - 12.24pm 26/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online